drugset / Trial / NCT01485094
A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this trial is to determine whether a novel analgesic is effective in treating of neuropathic pain caused by herpetic infection, surgery, or trauma.
Timeline
- Start
- 2012-02
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GRT6010 | Small molecule | — | Oral |
| Comparator | Pregabalin | Small molecule | 150 mg | Oral |